Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Czechia / NCT06792279
Starting soon Observational

Detection of Muscle Quality in Children - Protocol for a Validation Study

NCT06792279 · tracked via the Priya Life Science Czechia tracker
Sponsor
Charles University, Czech Republic
Phase
Observational
Started
2025-03-01
Last updated
2025-01-24

Condition(s) studied

Ultrasonography

Study summary

The goal of this observational study is to evaluate the validity and reliability of ultrasound echo intensity (EI) as a diagnostic tool for assessing muscle quality in children aged 10-14 years, including normal-weight, obese, and trained young athletes. The main questions it aims to answer are:

Can EI reliably and accurately measure muscle quality in children when validated against gold-standard techniques like DXA and isokinetic dynamometry? What are the age-, sex-, and fitness-specific benchmarks for EI to differentiate between normal and pathological muscle quality?

Eligibility

Sex
ALL
Min age
10 Years
Max age
14 Years
Healthy volunteers
Accepted
Inclusion Criteria: • Generally healthy children Exclusion Criteria: * Acute illnesses * Chronic or acute diseases of the endocrine or musculoskeletal systems * Post-traumatic conditions

Primary outcome measure(s)

  • Echo intensity of the vastus lateralis (VL) and rectus femoris (RF) muscles — Through study completion, an average of 1 year
    Echo intensity will be measured by greyscale analysis derivered from ultrasound imaging.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physical Education and Sport Charles University Prague Czech Republic

More Charles University, Czech Republic trials in Czechia

Immune Homeostasis in Sepsis and Septic Shock Recruiting
Exercise-Based Strategies for Chronic Back Pain Starting soon
PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery Active, not recruiting
Single-center Evaluation of Human Milk Quantity and Quality Over Five Years Recruiting
The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06792279 on ClinicalTrials.gov ↗ ← All trials in Czechia